Health Catalyst (HCAT) stock: insider trades, news & valuation
Health Care · Net buyingShare price and insider trades
Health Catalyst insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $106K and 2 sold $201K of HCAT stock on the open market.
Get emailed when insiders cluster-buy stocks like HCAT
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
HCAT insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $106K | 1 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | — | 0 | $201K | 2 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 Health Catalyst, Inc. insider reported open-market purchases totaling $106K, while 2 insiders reported sales totaling $201K. 1 of 2 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
HCAT stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 16SEC | Simeon KohlCEO | Buy | 59,0002,856,385 held (+2%) | $1.79 | $106K | -1.1% | — |
| Dec 9SEC | Julie Larson-greenDirector | Sell | 47,99773,573 held (−39%) | $2.67 | $128K | -33.7% | — |
| Dec 9SEC | Benjamin LandryGeneral Counsel | Sell Plan | 27,425100,000 held (−22%) | $2.64 | $72K | -33.0% | — |
Insiders at Health Catalyst, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Simeon KohlCEO | $106K | — | Sep 16, 2026 | — |
| Julie Larson-greenDirector | — | $128K | Dec 9, 2025 | — |
| Benjamin LandryGeneral Counsel | — | $72K | Dec 9, 2025 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
HCAT stock: common questions
Are Health Catalyst, Inc. insiders buying HCAT stock?
In the past 12 months, 1 insiders reported open-market purchases of HCAT worth $106K. The latest was CEO Simeon Kohl bought $106K of HCAT at $1.79 — first open-market purchase in our records.
Are Health Catalyst, Inc. insiders selling HCAT stock?
2 insiders reported sales worth $201K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is HCAT's 52-week range?
Over the past year HCAT has traded between $1.00 and $3.46. It last closed at $1.77 on Oct 9, 2026.